SCHEMBL17465265

SCHEMBL17465265

CC(C)(C)c1ccc(CN2CCCC(=O)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.47
KCNH2 Q12809 2/20 0.46
DRD2 P14416 2/20 0.45
HTR2A P28223 2/20 0.45
HTR2C P28335 2/20 0.45
HTR2B P41595 2/20 0.45
POLB P06746 1/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP2C9 P11712 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
LMNA P02545 1/20 0.40
NR1I2 O75469 1/20 0.40
ADORA3 P0DMS8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL797985 0.80 ALDH1A1 (0.59) SIGMAR1KCNH2KDM4EALDH1A1MEN1
SCHEMBL10212101 0.80 HRH3 (0.65) SIGMAR1KCNH2KDM4EALDH1A1MEN1
SCHEMBL6559974 0.80 ALDH1A1 (0.61) SIGMAR1KDM4EALDH1A1HRH3HDAC1
SCHEMBL15500352 0.80 TNIK (0.50) POLBKDM4EALDH1A1MEN1KMT2A
SCHEMBL568477 0.79 SIGMAR1 (0.53) SIGMAR1ALDH1A1HDAC1HDAC6
SCHEMBL12666600 0.79 HRH3 (0.69) SIGMAR1KCNH2POLBKDM4EALDH1A1
SCHEMBL270997 0.79 HRH3 (0.69) SIGMAR1KCNH2POLBKDM4EALDH1A1
Hydrochloric Acid SCHEMBL1243957 0.78 SIGMAR1 (0.52) SIGMAR1ALDH1A1HDAC1HDAC6
SCHEMBL1366467 0.78 L3MBTL1 (0.54) SIGMAR1POLBHRH3LMNA
Hydrochloric Acid SCHEMBL7407307 0.77 HRH3 (0.67) SIGMAR1KCNH2POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834521-B2 Choline kinase inhibitors ARIAD PHARMACEUTICALS, INC. (US) 2017-12-05 US disclosed
US-20160024024-A1 Novel Choline Kinase Inhibitors ARIAD PHARMACEUTICALS, INC. 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024024-A1 Novel Choline Kinase Inhibitors CHKA, CHKB, CEPT1 SIGMAR1 2499/4885KCNH2 1010/4885DRD2 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.